Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk
Crossref DOI link: https://doi.org/10.1007/s40291-018-0356-6
Published Online: 2018-09-14
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mitchell, Dominic
Guertin, Jason R.
LeLorier, Jacques
Funding for this research was provided by:
Genome Canada (CA) and Genome Quebec (4530)
Text and Data Mining valid from 2018-09-14